HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Yoshitaka Fujii Selected Research

dolasetron mesylate (dolasetron)

12/2011Management of postoperative nausea and vomiting in women scheduled for breast cancer surgery.
4/2011Current review of ramosetron in the prevention of postoperative nausea and vomiting.
3/2011Management of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
1/2008The benefits and risks of different therapies in preventing postoperative nausea and vomiting in patients undergoing thyroid surgery.
1/2006Prophylaxis of postoperative nausea and vomiting in patients scheduled for breast surgery.
1/2005The utility of antiemetics in the prevention and treatment of postoperative nausea and vomiting in patients scheduled for laparoscopic cholecystectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Yoshitaka Fujii Research Topics

Disease

63Neoplasms (Cancer)
10/2014 - 01/2002
41Lung Neoplasms (Lung Cancer)
07/2014 - 02/2002
31Postoperative Nausea and Vomiting (PONV)
12/2011 - 01/2002
29Breast Neoplasms (Breast Cancer)
05/2015 - 01/2003
28Vomiting
02/2011 - 01/2002
23Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2014 - 02/2002
22Nausea
02/2011 - 01/2002
21Neoplasm Metastasis (Metastasis)
07/2014 - 01/2002
17Thymoma (Thymic Carcinoma)
07/2015 - 12/2002
17Adenocarcinoma
07/2014 - 04/2004
17Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2014 - 01/2002
16Pain (Aches)
10/2009 - 01/2002
10Esophageal Neoplasms (Esophageal Cancer)
01/2010 - 01/2002
8Carcinoma (Carcinomatosis)
07/2014 - 01/2002
8Fatigue
05/2006 - 07/2002
5Strabismus (Squint)
04/2011 - 09/2002
5Hypercapnia
06/2010 - 01/2004
4Myasthenia Gravis
07/2015 - 12/2003
3Stomach Neoplasms (Stomach Cancer)
02/2009 - 03/2008
2Small Cell Carcinoma
01/2015 - 07/2014
2Neuroblastoma
05/2013 - 02/2003
2Multiple Endocrine Neoplasia Type 1 (MEN I)
10/2012 - 01/2006

Drug/Important Bio-Agent (IBA)

38Messenger RNA (mRNA)IBA
10/2014 - 01/2002
29Propofol (Diprivan)FDA LinkGeneric
12/2011 - 01/2002
26Epidermal Growth Factor Receptor (EGF Receptor)IBA
07/2014 - 04/2003
17Metoclopramide (Reglan)FDA LinkGeneric
12/2011 - 05/2002
16Estrogens (Estrogen)FDA Link
05/2015 - 03/2003
16Granisetron (Kytril)FDA LinkGeneric
12/2011 - 03/2002
16Dexamethasone (Maxidex)FDA LinkGeneric
12/2011 - 01/2002
15ramosetron (Nasea)IBA
12/2011 - 01/2002
14DroperidolFDA LinkGeneric
12/2011 - 05/2002
13Serotonin (5 Hydroxytryptamine)IBA
12/2011 - 01/2002
13gefitinib (Iressa)FDA Link
04/2009 - 06/2004
12AntiemeticsIBA
12/2011 - 05/2002
11Phosphotransferases (Kinase)IBA
10/2014 - 06/2004
8MicroRNAs (MicroRNA)IBA
01/2014 - 12/2006
8Lidocaine (Xylocaine)FDA LinkGeneric
10/2009 - 01/2002
7Progesterone Receptors (Progesterone Receptor)IBA
05/2015 - 01/2005
7Estrogen Receptor alphaIBA
10/2014 - 01/2005
7Ondansetron (Zofran)FDA LinkGeneric
12/2011 - 01/2005
6dolasetron mesylate (dolasetron)FDA Link
12/2011 - 01/2005
6tropisetron (Navoban)IBA
12/2011 - 01/2005
6HormonesIBA
11/2011 - 04/2002
6OxidoreductasesIBA
05/2008 - 01/2003
5Adenocarcinoma of lungIBA
01/2014 - 06/2004
5ButyrophenonesIBA
12/2011 - 01/2005
5flurbiprofen axetilIBA
04/2009 - 12/2004
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2012 - 08/2007
4Midazolam (Versed)FDA LinkGeneric
02/2011 - 09/2003
4Flurbiprofen (Froben)FDA LinkGeneric
04/2009 - 01/2004
4olprinoneIBA
06/2008 - 06/2003
3DNA (Deoxyribonucleic Acid)IBA
10/2013 - 03/2003
3PhenothiazinesIBA
03/2011 - 01/2005
3Histamine Antagonists (Antihistamines)IBA
03/2011 - 01/2005
3Carbon DioxideIBA
06/2010 - 05/2007
3Serine (L-Serine)FDA Link
11/2009 - 01/2005
3Cyclin D1IBA
11/2009 - 01/2007
3Estrogen Receptor betaIBA
11/2009 - 11/2007
3RNA (Ribonucleic Acid)IBA
02/2009 - 07/2002
3Codon (Codons)IBA
11/2008 - 01/2007
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2008 - 09/2002
3Pentobarbital (Nembutal)FDA Link
06/2008 - 05/2006
3Dopamine (Intropin)FDA LinkGeneric
11/2007 - 01/2004
3Matrix MetalloproteinasesIBA
12/2003 - 01/2002
3PPAR gammaIBA
02/2003 - 04/2002
2AntigensIBA
05/2014 - 08/2004
2Phenobarbital (Luminal)FDA Link
01/2014 - 02/2013
2Protein Kinases (Protein Kinase)IBA
10/2013 - 09/2008
2Complementary DNA (cDNA)IBA
05/2013 - 08/2004
2tyrosine receptor (receptor, tyrosine)IBA
05/2013 - 06/2004
2BenzamidesIBA
12/2011 - 03/2011
2Clonidine (ST 155)FDA LinkGeneric
12/2011 - 01/2006
2Insulin (Novolin)FDA Link
11/2011 - 08/2007
2Aromatase InhibitorsIBA
10/2011 - 01/2006
2PlatinumIBA
06/2011 - 10/2008
2Dimenhydrinate (DMH)FDA LinkGeneric
03/2011 - 01/2005
2Insulin-Like Growth Factor Binding Protein 5IBA
11/2009 - 08/2007
2TamoxifenFDA LinkGeneric
10/2009 - 01/2006
2erlotinib (CP 358,774)FDA Link
02/2009 - 08/2008
2Cholinergic Antagonists (Anticholinergics)IBA
09/2008 - 01/2005
2Scopolamine (Hyoscine)FDA Link
09/2008 - 01/2005
2Promethazine (Promet)FDA LinkGeneric
09/2008 - 01/2005
2benzamideIBA
09/2008 - 01/2005

Therapy/Procedure

25Anesthesia
12/2011 - 01/2002
16General Anesthesia
12/2011 - 01/2002
14Drug Therapy (Chemotherapy)
05/2015 - 01/2002
7Thyroidectomy
04/2011 - 05/2002
5Laparoscopic Cholecystectomy
04/2011 - 01/2002
4Tonsillectomy
04/2011 - 12/2003
3Thymectomy
07/2015 - 12/2003
3Dilatation and Curettage (D&C)
04/2011 - 01/2002
3Gynecologic Surgical Procedures (Gynecologic Surgery)
04/2011 - 02/2003
3Tourniquets
10/2009 - 08/2006
3Catheters
10/2009 - 08/2006
3Mastectomy (Mammectomy)
11/2008 - 01/2006
2Molecular Targeted Therapy
07/2014 - 07/2007
2Postoperative Care
03/2011 - 01/2009
2Adjuvant Chemotherapy
01/2011 - 01/2003
2Intravenous Injections
07/2009 - 05/2004
2Local Anesthesia
09/2008 - 08/2006